Annual EBITDA:
-$448.08M-$55.99M(-14.28%)Summary
- As of today, PCVX annual EBITDA is -$448.08 million, with the most recent change of -$55.99 million (-14.28%) on December 31, 2024.
- During the last 3 years, PCVX annual EBITDA has fallen by -$351.47 million (-363.79%).
- PCVX annual EBITDA is now -1479.25% below its all-time high of -$28.37 million, reached on December 31, 2018.
Performance
PCVX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$237.18M-$15.95M(-7.21%)Summary
- As of today, PCVX quarterly EBITDA is -$237.18 million, with the most recent change of -$15.95 million (-7.21%) on September 30, 2025.
- Over the past year, PCVX quarterly EBITDA has dropped by -$101.76 million (-75.14%).
- PCVX quarterly EBITDA is now -1903.23% below its all-time high of -$11.84 million, reached on September 30, 2019.
Performance
PCVX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$791.72M-$101.76M(-14.75%)Summary
- As of today, PCVX TTM EBITDA is -$791.72 million, with the most recent change of -$101.76 million (-14.75%) on September 30, 2025.
- Over the past year, PCVX TTM EBITDA has dropped by -$276.68 million (-53.72%).
- PCVX TTM EBITDA is now -5700.12% below its all-time high of -$13.65 million, reached on March 31, 2019.
Performance
PCVX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PCVX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -14.3% | -75.1% | -53.7% |
| 3Y3 Years | -363.8% | -321.9% | -372.8% |
| 5Y5 Years | -814.4% | -1029.0% | -836.4% |
PCVX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -363.8% | at low | -321.9% | at low | -372.8% | at low |
| 5Y | 5-Year | -814.4% | at low | -1140.4% | at low | -847.4% | at low |
| All-Time | All-Time | -1479.3% | at low | -1903.2% | at low | -5700.1% | at low |
PCVX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$237.18M(-7.2%) | -$791.72M(-14.7%) |
| Jun 2025 | - | -$221.23M(-25.8%) | -$689.95M(-11.6%) |
| Mar 2025 | - | -$175.92M(-11.8%) | -$618.23M(-11.7%) |
| Dec 2024 | -$448.08M(-14.3%) | -$157.38M(-16.2%) | -$553.69M(-7.5%) |
| Sep 2024 | - | -$135.42M(+9.4%) | -$515.03M(-5.1%) |
| Jun 2024 | - | -$149.50M(-34.2%) | -$490.16M(-15.2%) |
| Mar 2024 | - | -$111.38M(+6.2%) | -$425.40M(-11.1%) |
| Dec 2023 | -$392.10M(-83.2%) | -$118.73M(-7.4%) | -$382.87M(-17.7%) |
| Sep 2023 | - | -$110.55M(-30.4%) | -$325.42M(-20.0%) |
| Jun 2023 | - | -$84.75M(-23.1%) | -$271.10M(-16.8%) |
| Mar 2023 | - | -$68.85M(-12.4%) | -$232.07M(-16.0%) |
| Dec 2022 | -$214.03M | -$61.28M(-9.0%) | -$200.07M(-19.5%) |
| Sep 2022 | - | -$56.22M(-23.0%) | -$167.44M(-21.9%) |
| Jun 2022 | - | -$45.72M(-24.1%) | -$137.32M(-20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$36.85M(-28.7%) | -$114.46M(-14.2%) |
| Dec 2021 | -$96.61M(-10.0%) | -$28.64M(-9.7%) | -$100.22M(-10.5%) |
| Sep 2021 | - | -$26.11M(-14.2%) | -$90.70M(-6.0%) |
| Jun 2021 | - | -$22.86M(-1.1%) | -$85.61M(-2.4%) |
| Mar 2021 | - | -$22.62M(-18.3%) | -$83.57M(+5.2%) |
| Dec 2020 | -$87.81M(-79.2%) | -$19.12M(+9.0%) | -$88.17M(-4.3%) |
| Sep 2020 | - | -$21.01M(-0.9%) | -$84.55M(-12.2%) |
| Jun 2020 | - | -$20.82M(+23.5%) | -$75.38M(-13.4%) |
| Mar 2020 | - | -$27.21M(-75.5%) | -$66.49M(-25.6%) |
| Dec 2019 | -$49.00M(-72.7%) | -$15.51M(-31.0%) | -$52.93M(-41.4%) |
| Sep 2019 | - | -$11.84M(+0.8%) | -$37.42M(-46.3%) |
| Jun 2019 | - | -$11.93M(+12.6%) | -$25.58M(-87.4%) |
| Mar 2019 | - | -$13.65M | -$13.65M |
| Dec 2018 | -$28.37M | - | - |
FAQ
- What is Vaxcyte, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual EBITDA year-on-year change?
- What is Vaxcyte, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly EBITDA year-on-year change?
- What is Vaxcyte, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. TTM EBITDA year-on-year change?
What is Vaxcyte, Inc. annual EBITDA?
The current annual EBITDA of PCVX is -$448.08M
What is the all-time high annual EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual EBITDA is -$28.37M
What is Vaxcyte, Inc. annual EBITDA year-on-year change?
Over the past year, PCVX annual EBITDA has changed by -$55.99M (-14.28%)
What is Vaxcyte, Inc. quarterly EBITDA?
The current quarterly EBITDA of PCVX is -$237.18M
What is the all-time high quarterly EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly EBITDA is -$11.84M
What is Vaxcyte, Inc. quarterly EBITDA year-on-year change?
Over the past year, PCVX quarterly EBITDA has changed by -$101.76M (-75.14%)
What is Vaxcyte, Inc. TTM EBITDA?
The current TTM EBITDA of PCVX is -$791.72M
What is the all-time high TTM EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high TTM EBITDA is -$13.65M
What is Vaxcyte, Inc. TTM EBITDA year-on-year change?
Over the past year, PCVX TTM EBITDA has changed by -$276.68M (-53.72%)